Cagrilintide: Clinical Trials & Research
43 registered clinical trials and 46 peer-reviewed publications indexed for Cagrilintide, sourced from ClinicalTrials.gov and PubMed.
Clinical trials
- A Research Study to Compare Two Different Versions of Injectable CagriSema in People With Type 2 Diabetes
- A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body…
- A Research Study to See How Much CagriSema Lowers Blood Sugar and Body Weight Compared to Placebo in Children and…
- A Research Study to Compare Different Versions of Injectable CagriSema and Placebo in People With Excess Body Weight
- Evaluation of the Tolerability of Cagrilintide in Participants Not Tolerating GLP-1-RA Therapies Due to…
Research papers
- Efficacy of CagriSema for Reaching Anthropometric Treatment Targets and Cardiometabolic Outcomes: A Secondary, Post…
- Efficacy and safety of zalfermin co-administered with semaglutide in participants with fibrosis and cirrhosis due to…
- Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with type 2 diabetes inadequately…
- Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2):…
- Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2 diabetes (REIMAGINE 3): a…
See also: Cagrilintide full profile.
Study summaries on this site: Cagrilintide and CagriSema for weight reduction and metabolic risk modification in…, Cagrilintide-semaglutide (CagriSema) as an add-on to basal insulin in adults with type 2…, Cagrilintide-semaglutide (CagriSema) versus semaglutide or cagrilintide in people with…, Comparative Effectiveness of CagriSegma, Semaglutide, Cagrilintide and Tirzepatide in…, Efficacy and safety of once-weekly cagrilintide-semaglutide (CagriSema) in adults with…, Efficacy and safety of zalfermin co-administered with semaglutide in participants with…, Renal or Hepatic Impairment Does Not Affect Pharmacokinetics, Safety, or Tolerability of….